STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
RLMD RELMADA THERAPEUTICS INCORPORATED StockScouter® Report
7
StockScouter® Score
RELMADA THERAPEUTICS INCORPORATED, a small cap company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
- Moving average analysis for RLMD suggests strong price movement over the medium term. Positive
Concerns
- The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative
- Short-term relative price momentum exhibits moderate weakness. Neutral/Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
C
C
N/A
B